A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Preterm birth, poor foetal growth and anxiety disorders in a Finnish nationwide register sample




TekijätStåhlberg Tiia, Upadhyaya Subina, Khanal Prakash, Sucksdorff Minna, Luntamo Terhi, Suominen Auli, Sourander Andre

KustantajaWILEY

Julkaisuvuosi2022

Lehti: Acta Paediatrica

Tietokannassa oleva lehden nimiACTA PAEDIATRICA

Lehden akronyymiACTA PAEDIATR

Sivujen määrä10

ISSN0803-5253

DOIhttps://doi.org/10.1111/apa.16377

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Osittain avoin julkaisukanava

Verkko-osoitehttps://onlinelibrary.wiley.com/doi/epdf/10.1111/apa.16377

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/175437810


Tiivistelmä

Aim: We examined the associations between preterm birth, poor foetal growth and anxiety disorders among children and adolescents. Additionally, we examined the im-pact of common comorbidities and specific anxiety disorders separately.

Methods: Three  Finnish  registers  provided  data  on  a  nationwide  birth  cohort  of  22,181 cases with anxiety disorders and 74,726 controls. Conditional logistic regres-sion was used to examine the associations.

Results: Extremely very preterm birth and moderate- late preterm birth were associ-ated with increased adjusted odds ratios (aOR) for anxiety disorders (aOR 1.39, 95% CI  1.11–1.75  and  aOR  1.13,  95%  CI  1.03–1.23,  respectively).  Weight  for  gestational  age of less than −2SD (aOR 1.29, 95% CI 1.17–1.42) and −2SD to −1SD (aOR 1.08, 95% CI 1.03–1.14) were associated with increased odds ratios for anxiety disorders. When comorbidities were considered, the associations became statistically insignificant for pure anxiety disorders, but remained significant in the groups with comorbid depres-sive or neurodevelopmental disorders.

Conclusion: Preterm birth and poor foetal growth increased the odds for anxiety dis-orders. However, the associations seem to be explained by the conditions of comorbid depressive  and  neurodevelopmental  disorders.  Comorbidities  should  be  considered  when examining and treating child and adolescent anxiety disorders.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 14:39